USD 24.26
(-4.64%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 488.69 Million USD | 17.72% |
2022 | 415.14 Million USD | 20.06% |
2021 | 345.77 Million USD | 34.33% |
2020 | 257.41 Million USD | 24.44% |
2019 | 206.86 Million USD | 23.62% |
2018 | 167.33 Million USD | 146.33% |
2017 | 67.93 Million USD | 3.8% |
2016 | 65.44 Million USD | 3.95% |
2015 | 62.95 Million USD | 6.86% |
2014 | 58.91 Million USD | -4.88% |
2013 | 61.93 Million USD | 13.1% |
2012 | 54.75 Million USD | 11.74% |
2011 | 49 Million USD | 20.75% |
2010 | 40.58 Million USD | -30.84% |
2009 | 58.68 Million USD | 11.6% |
2008 | 52.58 Million USD | -2.95% |
2007 | 54.17 Million USD | 13.42% |
2006 | 47.77 Million USD | -9.45% |
2005 | 52.75 Million USD | 1.5% |
2004 | 51.97 Million USD | 10.07% |
2003 | 47.21 Million USD | 4.42% |
2002 | 45.22 Million USD | -31.28% |
2001 | 65.8 Million USD | -17.9% |
2000 | 80.15 Million USD | -6.03% |
1999 | 85.3 Million USD | 16.37% |
1998 | 73.3 Million USD | 17.47% |
1997 | 62.4 Million USD | 22.11% |
1996 | 51.1 Million USD | 31.7% |
1995 | 38.8 Million USD | 34.26% |
1994 | 28.9 Million USD | 53.72% |
1993 | 18.8 Million USD | 46.88% |
1992 | 12.8 Million USD | 36.17% |
1991 | 9.4 Million USD | -11.32% |
1990 | 10.6 Million USD | -20.3% |
1989 | 13.3 Million USD | -17.39% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q3 | 537.59 Million USD | 4.85% |
2024 Q2 | 512.74 Million USD | 4.1% |
2024 Q1 | 492.53 Million USD | 0.79% |
2023 Q4 | 488.69 Million USD | 3.64% |
2023 FY | 488.69 Million USD | 17.72% |
2023 Q3 | 471.52 Million USD | 7.01% |
2023 Q2 | 440.65 Million USD | 5.19% |
2023 Q1 | 418.9 Million USD | 0.9% |
2022 Q3 | 394.67 Million USD | 4.96% |
2022 Q2 | 376.02 Million USD | 7.08% |
2022 Q4 | 415.14 Million USD | 5.19% |
2022 Q1 | 351.17 Million USD | 1.56% |
2022 FY | 415.14 Million USD | 20.06% |
2021 Q4 | 345.77 Million USD | 6.52% |
2021 FY | 345.77 Million USD | 34.33% |
2021 Q1 | 265.8 Million USD | 3.26% |
2021 Q2 | 294.43 Million USD | 10.77% |
2021 Q3 | 324.6 Million USD | 10.25% |
2020 FY | 257.41 Million USD | 24.44% |
2020 Q4 | 257.41 Million USD | 9.68% |
2020 Q3 | 234.69 Million USD | 7.64% |
2020 Q2 | 218.03 Million USD | 5.44% |
2020 Q1 | 206.78 Million USD | -0.04% |
2019 Q4 | 206.86 Million USD | 7.33% |
2019 FY | 206.86 Million USD | 23.62% |
2019 Q2 | 185.96 Million USD | 4.93% |
2019 Q3 | 192.74 Million USD | 3.65% |
2019 Q1 | 177.21 Million USD | 5.9% |
2018 Q4 | 167.33 Million USD | 2.67% |
2018 Q1 | 78.29 Million USD | 15.25% |
2018 FY | 167.33 Million USD | 146.33% |
2018 Q2 | 82.7 Million USD | 5.64% |
2018 Q3 | 162.98 Million USD | 97.06% |
2017 Q1 | 65.43 Million USD | -0.01% |
2017 Q2 | 63.63 Million USD | -2.76% |
2017 Q3 | 72.7 Million USD | 14.25% |
2017 FY | 67.93 Million USD | 3.8% |
2017 Q4 | 67.93 Million USD | -6.56% |
2016 FY | 65.44 Million USD | 3.95% |
2016 Q3 | 66.33 Million USD | 1.58% |
2016 Q2 | 65.3 Million USD | 5.53% |
2016 Q1 | 61.88 Million USD | -1.71% |
2016 Q4 | 65.44 Million USD | -1.34% |
2015 Q4 | 62.95 Million USD | 1.69% |
2015 FY | 62.95 Million USD | 6.86% |
2015 Q1 | 56.8 Million USD | -3.57% |
2015 Q2 | 60.29 Million USD | 6.14% |
2015 Q3 | 61.91 Million USD | 2.68% |
2014 Q2 | 64.37 Million USD | 0.1% |
2014 Q1 | 64.3 Million USD | 3.84% |
2014 FY | 58.91 Million USD | -4.88% |
2014 Q4 | 58.91 Million USD | -6.18% |
2014 Q3 | 62.79 Million USD | -2.45% |
2013 Q3 | 59.53 Million USD | 8.91% |
2013 Q1 | 52.65 Million USD | -3.84% |
2013 FY | 61.93 Million USD | 13.1% |
2013 Q4 | 61.93 Million USD | 4.02% |
2013 Q2 | 54.66 Million USD | 3.81% |
2012 Q2 | 49.84 Million USD | 2.94% |
2012 Q3 | 51.82 Million USD | 3.98% |
2012 Q4 | 54.75 Million USD | 5.65% |
2012 FY | 54.75 Million USD | 11.74% |
2012 Q1 | 48.42 Million USD | -1.2% |
2011 FY | 49 Million USD | 20.75% |
2011 Q3 | 45.89 Million USD | 7.63% |
2011 Q2 | 42.64 Million USD | 6.09% |
2011 Q1 | 40.19 Million USD | -0.96% |
2011 Q4 | 49 Million USD | 6.77% |
2010 FY | 40.58 Million USD | -30.84% |
2010 Q4 | 40.58 Million USD | 5.08% |
2010 Q1 | 54.48 Million USD | -7.15% |
2010 Q2 | 37.53 Million USD | -31.11% |
2010 Q3 | 38.62 Million USD | 2.89% |
2009 Q1 | 49.85 Million USD | -5.18% |
2009 Q2 | 59.32 Million USD | 18.99% |
2009 FY | 58.68 Million USD | 11.6% |
2009 Q4 | 58.68 Million USD | -0.92% |
2009 Q3 | 59.22 Million USD | -0.17% |
2008 Q2 | 58.9 Million USD | -5.82% |
2008 Q1 | 62.53 Million USD | 15.43% |
2008 FY | 52.58 Million USD | -2.95% |
2008 Q4 | 52.58 Million USD | -5.53% |
2008 Q3 | 55.66 Million USD | -5.5% |
2007 Q1 | 50.08 Million USD | 4.85% |
2007 FY | 54.17 Million USD | 13.42% |
2007 Q4 | 54.17 Million USD | 0.0% |
2007 Q3 | 54.17 Million USD | -4.01% |
2007 Q2 | 56.43 Million USD | 12.68% |
2006 FY | 47.77 Million USD | -9.45% |
2006 Q3 | 48.73 Million USD | -1.65% |
2006 Q4 | 47.77 Million USD | -1.98% |
2006 Q2 | 49.55 Million USD | -1.4% |
2006 Q1 | 50.25 Million USD | -4.74% |
2005 Q3 | 55.25 Million USD | -4.18% |
2005 Q1 | 47.54 Million USD | -8.52% |
2005 FY | 52.75 Million USD | 1.5% |
2005 Q2 | 57.66 Million USD | 21.28% |
2005 Q4 | 52.75 Million USD | -4.52% |
2004 Q4 | 51.97 Million USD | -2.9% |
2004 FY | 51.97 Million USD | 10.07% |
2004 Q1 | 45.64 Million USD | -3.33% |
2004 Q2 | 55.67 Million USD | 21.98% |
2004 Q3 | 53.52 Million USD | -3.87% |
2003 FY | 47.21 Million USD | 4.42% |
2003 Q4 | 47.21 Million USD | -7.38% |
2003 Q3 | 50.98 Million USD | -2.18% |
2003 Q2 | 52.11 Million USD | 15.8% |
2003 Q1 | 45 Million USD | -0.47% |
2002 Q3 | 58.11 Million USD | -6.92% |
2002 Q2 | 62.43 Million USD | -2.36% |
2002 Q1 | 63.94 Million USD | -2.83% |
2002 Q4 | 45.22 Million USD | -22.19% |
2002 FY | 45.22 Million USD | -31.28% |
2001 FY | 65.8 Million USD | -17.9% |
2001 Q1 | 79.88 Million USD | -0.33% |
2001 Q2 | 76.1 Million USD | -4.73% |
2001 Q4 | 65.8 Million USD | -12.5% |
2001 Q3 | 75.2 Million USD | -1.18% |
2000 Q3 | 96.64 Million USD | 25.55% |
2000 FY | 80.15 Million USD | -6.03% |
2000 Q1 | 91.58 Million USD | 7.37% |
2000 Q4 | 80.15 Million USD | -17.07% |
2000 Q2 | 76.97 Million USD | -15.95% |
1999 Q3 | 78.8 Million USD | 5.07% |
1999 Q2 | 75 Million USD | 1.63% |
1999 Q1 | 73.8 Million USD | 0.68% |
1999 FY | 85.3 Million USD | 16.37% |
1999 Q4 | 85.3 Million USD | 8.25% |
1998 FY | 73.3 Million USD | 17.47% |
1998 Q3 | 70.3 Million USD | -1.26% |
1998 Q4 | 73.3 Million USD | 4.27% |
1998 Q1 | 69.1 Million USD | 10.74% |
1998 Q2 | 71.2 Million USD | 3.04% |
1997 FY | 62.4 Million USD | 22.11% |
1997 Q1 | 49.9 Million USD | -2.35% |
1997 Q2 | 53 Million USD | 6.21% |
1997 Q3 | 53.7 Million USD | 1.32% |
1997 Q4 | 62.4 Million USD | 16.2% |
1996 Q3 | 50.2 Million USD | 13.06% |
1996 Q1 | 42.1 Million USD | 8.51% |
1996 FY | 51.1 Million USD | 31.7% |
1996 Q4 | 51.1 Million USD | 1.79% |
1996 Q2 | 44.4 Million USD | 5.46% |
1995 Q2 | 33 Million USD | 8.55% |
1995 Q4 | 38.8 Million USD | 11.17% |
1995 FY | 38.8 Million USD | 34.26% |
1995 Q1 | 30.4 Million USD | 5.19% |
1995 Q3 | 34.9 Million USD | 5.76% |
1994 Q3 | 23 Million USD | 10.58% |
1994 Q1 | 19.3 Million USD | 2.66% |
1994 Q2 | 20.8 Million USD | 7.77% |
1994 FY | 28.9 Million USD | 53.72% |
1994 Q4 | 28.9 Million USD | 25.65% |
1993 Q2 | 15.1 Million USD | 0.0% |
1993 FY | 18.8 Million USD | 46.88% |
1993 Q4 | 18.8 Million USD | 17.5% |
1993 Q3 | 16 Million USD | 5.96% |
1992 Q4 | 12.8 Million USD | 0.0% |
1992 FY | 12.8 Million USD | 36.17% |
1991 Q4 | 9.4 Million USD | 0.0% |
1991 Q1 | 10.9 Million USD | 2.83% |
1991 FY | 9.4 Million USD | -11.32% |
1990 FY | 10.6 Million USD | -20.3% |
1990 Q4 | 10.6 Million USD | 0.0% |
1989 FY | 13.3 Million USD | -17.39% |
1989 Q4 | 13.3 Million USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Akoya Biosciences, Inc. | 180.36 Million USD | -170.94% |
AngioDynamics, Inc. | 317.67 Million USD | -53.836% |
AtriCure, Inc. | 613.93 Million USD | 20.4% |
Avinger, Inc. | 13.77 Million USD | -3448.962% |
Azenta, Inc. | 2.88 Billion USD | 83.065% |
BioLife Solutions, Inc. | 412.71 Million USD | -18.409% |
The Cooper Companies, Inc. | 11.65 Billion USD | 95.808% |
Daxor Corporation | 34.86 Million USD | -1301.503% |
Ekso Bionics Holdings, Inc. | 28.91 Million USD | -1589.923% |
Femasys Inc. | 27.75 Million USD | -1660.683% |
GlucoTrack, Inc. | 4.9 Million USD | -9863.14% |
Harvard Bioscience, Inc. | 137.36 Million USD | -255.759% |
Hologic, Inc. | 9.15 Billion USD | 94.663% |
ICU Medical, Inc. | 4.37 Billion USD | 88.839% |
Intuitive Surgical, Inc. | 15.44 Billion USD | 96.835% |
KORU Medical Systems, Inc. | 28.46 Million USD | -1617.06% |
LeMaitre Vascular, Inc. | 346.77 Million USD | -40.924% |
Innovative Eyewear, Inc. | 6.21 Million USD | -7758.349% |
Innovative Eyewear, Inc. | 6.21 Million USD | -7758.349% |
Masimo Corporation | 3.04 Billion USD | 83.933% |
Microbot Medical Inc. | 8.32 Million USD | -5768.764% |
Meihua International Medical Technologies Co., Ltd. | 171.91 Million USD | -184.263% |
Merit Medical Systems, Inc. | 2.32 Billion USD | 78.983% |
Nephros, Inc. | 11.86 Million USD | -4020.159% |
NovoCure Limited | 1.14 Billion USD | 57.362% |
NEXGEL, Inc. | 9.95 Million USD | -4809.011% |
NEXGEL, Inc. | 9.95 Million USD | -4809.011% |
Singular Genomics Systems, Inc. | 265.46 Million USD | -84.088% |
OraSure Technologies, Inc. | 482.84 Million USD | -1.211% |
Pro-Dex, Inc. | 54.21 Million USD | -801.479% |
Pulse Biosciences, Inc. | 60.8 Million USD | -703.717% |
Predictive Oncology Inc. | 14.41 Million USD | -3289.634% |
Precision Optics Corporation, Inc. | 16.91 Million USD | -2789.519% |
QuidelOrtho Corporation | 8.56 Billion USD | 94.293% |
Repligen Corporation | 2.82 Billion USD | 82.698% |
Sanara MedTech Inc. | 73.87 Million USD | -561.546% |
Sharps Technology, Inc. | 11.78 Million USD | -4045.228% |
Utah Medical Products, Inc. | 135.45 Million USD | -260.77% |
DENTSPLY SIRONA Inc. | 7.37 Billion USD | 93.369% |
Jin Medical International Ltd. | 32.9 Million USD | -1385.23% |